Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|February 7, 2016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapyRémi Rosière, Matthias Van Woensel, Véronique Mathieu, et al.
Molecular Pharmacology|November 19, 2005
Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptorsMagali Foucaud, Irina G Tikhonova, Ingrid Langer, et al.
Cellular Signalling|May 22, 2002
VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cellsIngrid Langer, Pascale Vertongen, Jason Perret, et al.
Frontiers in Endocrinology|April 21, 2018
Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor FunctionXavier Peyrassol, Toon Laeremans, Vannessa Lahura, et al.
The Journal of Biological Chemistry|April 9, 2005
Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokininIngrid Langer, Irina G Tikhonova, Marie-Agnès Travers, et al.
Regulatory Peptides|October 27, 2007
Insights into the binding and activation sites of the receptors for cholecystokinin and gastrinMagali Foucaud, Elodie Archer-Lahlou, Esther Marco, et al.
ACS Synthetic Biology|May 14, 2016
Modular Integrated Secretory System Engineering in Pichia pastoris To Enhance G-Protein Coupled Receptor ExpressionKatrien Claes, Kristof Vandewalle, Bram Laukens, et al.
Frontiers in Cell and Developmental Biology|August 7, 2025
Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroidsGiulia Agostini, Morgane Leprovots, Jérôme Jeandriens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2016
Development by Genetic Immunization of Monovalent Antibodies (Nanobodies) Behaving as Antagonists of the Human ChemR23 ReceptorXavier Peyrassol, Toon Laeremans, Mieke Gouwy, et al.
Molecular Pharmacology|December 10, 2008
Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptorIngrid Langer, Irina G Tikhonova, Cyril Boulègue, et al.
Pageof 5